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Exposure to N-chlorotaurine induces oxidative stress
responses in Aspergillus fumigatus
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Abstract
Purpose. The neutrophil-derived oxidant N-chlorotaurine (NCT) displays remarkable in vivo tolerability and efficacy against a
range of pathogens. The aim of this study was to characterize the response of the pulmonary pathogen Aspergillus fumigatus
to NCT.
Methodology. The effect of NCT on the growth and viability of A. fumigatus was characterized. NCT-induced alteration of
amino acids and gliotoxin from A. fumigatus mycelium was assessed. Label-free shotgun quantitative proteomic analysis
was performed on A. fumigatus exposed to NCT for 24 h.
Results. Incubation of A. fumigatus with NCT at concentrations ranging from 6.8 to 55mM decreased conidial growth and
viability, and mycelium biomass relative to the controls. Exposure to NCT (13.77mM) resulted in increased amino acids and
gliotoxin levels from A. fumigatus mycelium. Exposure of A. fumigatus mycelium to NCT (6.8mM) revealed an enrichment in
proteins associated with the ribosome, transcription and translation and non-ribosomal peptide biosynthesis (e.g. Pes1,
Pes3), which play an essential role in oxidative stress resistance in A. fumigatus. A decrease in the abundance of proteins
associated with fumagillin and pseurotin biosynthesis highlighted the anti-virulence activity of NCT.
Conclusion. These results indicate that NCT induces an oxidative stress response in A. fumigatus as evidenced by alterations
in the proteome and inhibits conidial and mycelial growth. Clinical investigations of topical application of NCT to treat
Aspergillus infections are encouraged.
INTRODUCTION
Aspergillus fumigatus is a ubiquitous filamentous fungus
that produces small (3–5 µm) airborne conidia, which are
readily dispersed into the surrounding environment and
inhaled [1]. A. fumigatus is capable of inducing a wide range
of diseases, which are dependent upon the host immune sta-
tus. Colonization, saprophytic and allergic disease are gen-
erally observed in the immune-defective host [e.g.
asthmatic, cystic fibrosis (CF)], while invasive aspergillosis
is observed in neutropenic and immune-suppressed
patients, and carries a high mortality rate (30–95%) if quick
and effective anti-fungal therapy is not commenced [2, 3].
In the immunocompetent host, non-specific mucociliary
clearance and a robust and efficient humoral (Pentraxin 3,
complement proteins, collectins, ficolins, antimicrobial pep-
tides) and cellular (neutrophils, alveolar macrophages, type
II pneumocytes) response eliminate the fungal threat [2].
However, when the immune system becomes compromised
A. fumigatus conidia germinate, produce hyphae and grow
between and through alveolar epithelial cells by the produc-
tion of a range of tissue-degrading enzymes and immuno-
suppressive toxins. A. fumigatus virulence is multifaceted
and includes the production of low molecular weight toxins,
proteolytic enzymes, thermotolerance, immune detoxifica-
tion mechanisms and metabolic adaptations [1, 4]. The
hyphae of A. fumigatus produce gliotoxin and fumagillin
and these have been shown to inhibit fungicidal activity of
neutrophils [5, 6]. Gliotoxin has pleotropic immune-sup-
pressive activities and can induce macrophage apoptosis,
inactivation of neutrophil NADPH-oxidase and has been
implicated in destruction of lung tissue during invasive
aspergillosis [7, 8]. A. fumigatus also produces several non-
ribosomal peptides (NRP) such as pes1 and pes3 [9, 10].
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The former (pes1) plays a role in fungal tolerance to oxida-
tive stress, mediated by the conidial phenotype [9].
The importance of an effective neutrophil response to A.
fumigatus was characterized in several studies that demon-
strated that neutrophil depletion in mice resulted in higher
mortality rates [11, 12]. Neutrophils employ both oxidative
and non-oxidative mechanisms to eradicate conidia, germ-
lings and hyphae of A. fumigatus by phagocytosis, degranu-
lation of proteolytic enzymes and antimicrobial peptides
and the production of NADPH-oxidase-mediated reactive
oxygen species (ROS) [13]. The importance of a functional
NADPH oxidase is highlighted in chronic granulomatous
disease, characterized by mutations in p47phox and thus
defective cellular oxidative killing mechanisms. NADPH-
oxidase defective (gp91phox / ) mice are unable to inhibit
conidial germination and their lung tissue displays expan-
sive hyphal proliferation and tissue invasion as well as neu-
trophil aggregates, not observed in wild-type mice [14, 15].
Activated neutrophils through a series of enzymatic
reactions produce superoxide and hydrogen peroxide
with NADPH oxidase and superoxide dismutase, respec-
tively, and hypochlorous acid (HOCl) is formed from
hydrogen peroxide (H2O2) and chloride by myeloperoxi-
dase [16]. HOCl in the presence of taurine results in
the formation of N-chlorotaurine (NCT; Cl-HN-CH2-
CH2-SO3H) [17, 18]. NCT is the most abundant repre-
sentation of this class of compounds and is a long-lived
oxidant [19]. Chloramine has been detected in superna-
tants from stimulated granulocytes at concentrations
ranging from 30 to 100 µM [17]. NCT is the main con-
stituent of these compounds, reaching concentrations of
between 10 to 50 µM [19, 20]. NCT is bactericidal, fun-
gicidal, virucidal and vermicidical at concentrations
ranging from 100 µM to 55mM and non-cytotoxic up
to 0.5mM [21, 22]. Bronchial exudates from CF patients
display chloramine concentrations of 118±25 µM [23],
indicating a high level of NCT present extracellularly in
vivo, which is continually replenished by activated neu-
trophilic and eosinophilic granulocytes, monocytes and,
in small amounts, probably macrophages [24, 25]. The
microbicidal activity of NCT is enhanced in CF sputum
medium against a range of common CF pathogens [26].
NCT is non-toxic and well tolerated. For example, inha-
lation and topical application to the skin, eye, middle
ear, oral cavity and bladder with 1% (10 mg ml 1;
55mM) appears to be safe [21]. NCT eradicated bacte-
rial conjunctivitis within 5 days in a Phase IIa open pilot
study [27]. Furthermore, NCT was superior to a combi-
nation of neomycin, polymyxin B and hydrocortisone at
decreasing inflammation and infection of external otitis
[28]. NCT (1%; 55mM) results in a>5 log10-fold reduc-
tion in the c.f.u. of MRSA, Streptococcus pyogenes,
Escherichia coli and Pseudomonas aeruginosa after 1 h
incubation [21]. NCT significantly deceased the viability
of medically important fungi including Candida albicans
(up to 4.7 log10-fold reduction in c.f.u.) and A.
fumigatus (up to 2.6 log10-fold reduction in c.f.u.) after
4 h exposure [21]. NCT decreased virulence factor pro-
duction and activity from C. albicans (secreted aspartyl
proteinases) and A. fumigatus (gliotoxin), respectively,
before viability of these fungi was impaired probably as
a result of oxidative stress interfering with protein syn-
thesis [29, 30]. Moreover, Scedosporium spp. lost viru-
lence in the Galleria mellonella model after sublethal
incubation time in NCT [31]. A similar effect has been
observed with Staphylococci and Streptococci [26, 32].
The activity of NCT is augmented in the presence of
hydrogen peroxide [33].
Neutrophils are the first line of defense against A. fumigatus
and this is demonstrated by the high incidence of invasive
aspergillosis in chronic granulomatous disease (CGD)
patients who lack functional neutrophils [34]. A. fumigatus
is engulfed into the phagosome and encounters NCT during
the oxidative killing process. A. fumigatus comes into con-
tact with NCT in CF bronchoalveolar lavage fluid. A. fumi-
gatus has extensive mechanisms to circumvent and detoxify
PMNs killing including oxidative mechanisms [35]. In order
to elucidate the role of NCT in the human defense system
and its potential for topical application as an anti-infective,
it was the aim of this study to determine its mode of action




N-chlorotaurine (NCT) (molecular mass 181.57 g mol 1, lot
2015-02-05) was prepared as a crystalline sodium salt at
pharmaceutical grade in our laboratory, as reported previ-
ously [36], stored at  20

C, and freshly dissolved in sterile
distilled water to a concentration of 0.68, 6.8, 13.77mM etc.
for each experiment.
A. fumigatus culture conditions
A. fumigatus ATCC 26933, ATCC 46645, Af293 were
obtained from the American Type Culture Collection and
grown in sabouraud dextrose broth (SAB) or minimal
essential media supplemented with 5% v/v fetal calf serum
at 37

C and 200 r.p.m. Stocks were grown (for 3 days) and
maintained on malt extract agar (MEA) (Oxoid) and used
within 5 days.
Impact of N-chlorotaurine on the viability of
A. fumigatus conidia (quantitative killing assay)
A. fumigatus (ATCC 26933) conidia (5107) were incu-
bated in 1ml PBS supplemented with NCT (final concentra-
tions; 0.68–68mM) for 0, 1, 4, 24 h at 37

C. Aliquots (20 µl)
were taken and serially diluted at each time point, and
100 µl of diluted sample was spread onto MEA agar plates.
Resulting colonies were counted and expressed in terms of
% growth relative to the control, (n=3). The detection limit
was 102 c.f.u. ml 1 after 1 h incubation. Because of rapid
inactivation of NCT after the dilution on the plates within
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3min [31], no inactivation substance was necessary after
these long incubation times.
Assessment of effect of N-chlorotaurine on
A. fumigatus conidia
MEA plates containing sporulating A. fumigatus (ATCC
26933, ATCC 46645, Af293) colonies were washed with
0.1% (v/v) Tween 80 (Merck) in PBS (pH 7.2) (Sigma
Aldrich) to isolate conidia. Conidia were washed twice in
sterile PBS, centrifuged (1500 g, 5min in a Beckman GS-6
centrifuge) and enumerated using a haemocytometer. NCT
was serially diluted in growth medium (SAB or MEM
+5%FCS; 0.21mM to 55mM) on a 96-well plate (Corning
Costar) and Aspergillus conidia (1104 well 1) were added
to each well. Plates were incubated at 37

C and growth was
quantified by measuring readings at OD 570 (Bio-Tek Syn-
ergy HT) at 48 h, (n=3).
Inhibition of growth of A. fumigatus hyphae by
N-chlorotaurine (biomass evaluation)
Flasks containing SAB (25ml) were inoculated with
2.5106 A. fumigatus (ATCC 26933, ATCC46645, Af293)
conidia to give a density of 1105 ml 1 and incubated at
37

C and 200 r.p.m. for 24 h. Cultures were supplemented
with 1ml of NCT PBS solution or 1ml PBS (control) for a
further 24 h when hyphal wet weights were determined,
(n=4).
Effect of N-chlorotaurine on A. fumigatus mycelium
membrane permeability
Flasks containing SAB (25ml) were inoculated with
2.5106 A. fumigatus (ATCC 26933, ATCC46645, Af293)
conidia to give a density of 1105 ml 1 and incubated at
37

C and 200 r.p.m. for 24 h. Cultures were supplemented
with NCT (0.68–13.77mM) or PBS (control) and incubated
for a further 24 h, (n=4). A. fumigatus cultures were filtered
using mira-cloth and 0.22 µm cellulose filters (Sarstedt).
Amino acid leakage by A. fumigatus was determined using
the ninhydrin colorimetric method and expressed in terms
of aspartic acid and glutamic acid [37]. Ninhydrin (Sigma-
Aldrich) was dissolved in ethanol to give a final concentra-
tion of 0.35% (w/v) and 250 µl was added to each culture fil-
trate sample (1ml) and heated to 95

C for 4min followed
by cooling on ice. The absorbance at 570 nm was recorded
on a spectrophotometer (Beckman DU 640). Gliotoxin
extraction from culture medium was performed as
described [37]. Filtered culture supernatants were mixed
with an equal volume (20ml) of chloroform (Hyper Solv;
BDH) for 2 h. For extraction of intracellular gliotoxin,
mycelium was washed in PBS, ground to a fine powder with
liquid N2 in a pre-chilled pestle and mortar, resuspended in
10ml 6 M HCl for 10 mins followed by the addition of chlo-
roform (20ml) to the mixture for 2 h, stirring at room tem-
perature. The chloroform fraction was collected and
evaporated to dryness in a Büchi (Brinkmann Instruments;
Westbury, NY) rotor evaporator. Dried extracts were dis-




Quantification of gliotoxin by RP-HPLC
Gliotoxin was detected by reversed phase-HPLC (Spectra-
Physics). The mobile phase was 34.9% (v/v) acetonitrile
(Hyper Solv, BDH), 0.1% (v/v) trifluoroacetic acid (Sigma
Aldrich) and 65% (v/v) ddH2O. Gliotoxin extract (20 µl)
was injected onto a C18 Hewlett Packard column. A stan-
dard curve of peak area versus gliotoxin concentration was
constructed using gliotoxin standards (0.1, 0.2, 0.5, 1.0 µg
10 µl 1) dissolved in methanol (Sigma Aldrich).
Whole cell protein extraction from A. fumigatus
Mycelium (1 g) was ground to a fine powder in a pestle and
mortar with liquid nitrogen followed by the addition of 6ml
of protein extraction buffer [0.4 M NaCl, 10mM Tris HCl,
2mM EDTA, 10% (v/v) glycerol] supplemented with apro-
tinin (10 µg ml 1), peptstatin A (10 µg ml 1), TLCK (10 µg
ml 1) leupeptin (10 µg ml 1). The suspension was disrupted
using a sonication probe (Bandelin Sonopuls, Bandelin elec-
tronic, Berlin) at 20% power, cycle 6 for 10 s. This was
repeated twice with the sample being cooled on ice between
each sonication. Protein supernatants were obtained by cen-
trifugation (10 000 g, 4

C for 20min).
Label-free quantitative proteomics of A. fumigatus
protein lysate
Label-free shotgun quantitative proteomic analysis was per-
formed on protein extracted from control and NCT
(6.8mM) treated A. fumigatus (ATCC 26933) hyphae for
24 h at 37

C in SAB medium, (n=3). As described elsewhere
[37], protein (75 µg) was reduced with dithiotreitol (DTT;
200mM) (Sigma-Aldrich), alkylated with iodoacetamide
(IAA; 1 M) (Sigma-Aldrich) and digested with sequence
grade trypsin (Promega, Ireland) at a trypsin:protein ratio
of 1 : 40, overnight at 37

C. Tryptic peptides were purified
for mass spectrometry using C18 spin filters (Medical Sup-
ply Company, Ireland) and 1 µg of peptide mix was eluted
onto a Q-Exactive (ThermoFisher Scientific, USA) high res-
olution accurate mass spectrometer connected to a Dionex
Ultimate 3000 (RSLCnano) chromatography system.
Protein identification from the MS/MS data was performed
using the Andromeda search engine in MaxQuant (version
1.6.0.16; http://maxquant.org/) to correlate the data against
an annotated database derived from the A. fumigatus Af293
Reference proteome downloaded from Uniprot [38, 39].
Results processing, statistical analyses and graphics genera-
tion were conducted using Perseus v. 1.5.5.3. Label-free
quantification (LFQ) intensities were log2-transformed. Sta-
tistical differences between the NCT treated and control A.
fumigatus hyphal proteomes were tested using ANOVA and
t-tests with false discovery rate (FDR) correction (Benja-
mini-Hochberg). P-values of <0.05 were considered signifi-
cant. Proteins that had non-existent values (indicative of
absence or very low abundance in a sample) were included
in the study only when they were completely absent from
one group and present in at least two of the three replicates
in the second group. Identified proteins were grouped into
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functional categories based on the FunCat (Functional Cata-
logue) and GO (Gene Ontology) annotations, using the
FungiFun application [40].
Statistical analysis
All experiments were performed on at least three indepen-
dent occasions and results are expressed as the mean±stan-
ndard error. Statistical analysis was performed using one-
way ANOVA with Tukey’s multiple comparison test for
susceptibility and flask assays (wet weight and gliotoxin)
with values of P<0.05 considered statistically significant as
compared to controls. All statistical analysis listed was per-
formed using GraphPad Prism [v 6.0].
Data availability
The MS proteomics data and MaxQuant search output files
have been deposited to the ProteomeXchange Consortium
[41] via the PRIDE partner repository with the dataset iden-
tifier PXD009853.
RESULTS
Effects of N-chlorotaurine on the growth and
viability of A. fumigatus
The growth response of A. fumigatus (ATCC 26933) to
NCT was assessed in vitro using a susceptibility assay. Expo-
sure of A. fumigatus to 6.8 and 55mM NCT reduced growth
to 6.42±0.43% and 5.22±0.43%, respectively, relative to the
control in SAB after 48 h (P<0.001). A concentration of
3.44mM reduced growth by 9.83±3.64%, (P<0.05) (Fig. 1).
NCT at 55mM reduced growth of A. fumigatus in minimal
essential media (MEM) +5% fetal calf serum (FCS) to 70.67
±1.29%, and 3.4mM NCT reduced growth to 78.17
±11.01%, but this was less in MEM +5%FCS as compared
to SAB, (Fig. S1a, available in the online version of this arti-
cle). NCT also reduced the growth of other A. fumigatus
strains (ATCC46645 and Af293) at concentrations ranging
from 3.44 to 55mM (Fig. S1b and c). The effect of NCT on
the growth A. flavus was also determined and 55mM NCT
reduced growth to 6.84±0.04% (P<0.0001) and 3.44mM
NCT reduced growth to 28.37±1.81% (P<0.0001) compared
to the control (98.74±4.49%), (Fig. S1d).
To assess the effect of NCT on mycelium biomass accumu-
lation, 24 h preformed mycelium was supplemented with
NCT (0.68 to 13.77mM) for a further 24 h. A NCT concen-
tration of 0.68mM reduced biomass formation (0.75
±0.06 g/ (25ml culture)–1, P<0.01). A concentration of 6.8
(0.64±0.04 g/ (25ml culture)–1, P<0.001) and 13.77mM
(0.18±0.009 g, P<0.0001) resulted in a statistically significant
decrease in mycelium wet weight compared to the control
(1.03±0.055 g), (Fig. 2). This decrease in mycelium biomass
was also noted with A. fumigatus strains (ATCC 46645 and
Af293) and A. flavus. A concentration of 13.77 and
0.68mM reduced mycelium biomass of A. fumigatus ATCC
46645 to 0.138±0.004, (P<0.05) and 0.637±0.03 g/ (25ml
culture)–1, (P<0.0001), respectively, as compared to the con-
trol (0.741±0.008), (Fig. 2a). NCT (13.77mM) significantly
reduced the biomass accumulation of A. fumigatus Af293 to
0.319±0.05 g/ (25ml culture)–1, (P<0.01) as compared to the
relative control (0.682±0.03 g), (Fig. S2b). Furthermore,
NCT also reduced the mycelium wet weight of A. flavus at
13mM (0.531±0.03, P<0.01) and 6.8mM (0.656±0.01,
P<0.01) as compared to control mycelium ([0.857±0.003 g/
(25ml culture)–1]), (Fig. S2c).
Incubation of A. fumigatus (ATCC 26933) conidia in NCT
for 1, 4 and 24 h at concentrations ranging from 6.8 to
68mM decreased the viability of conidia in a dose- and
time-dependent manner. Incubation of conidia in PBS sup-
plemented with 68mM NCT reduced viability at 1 (28.73
±7.78%, P<0.05), 4 (0±0.0007%, P<0.05) and 24 (0%
±0.0034%, P<0.05) h and incubation in 6.8mM NCT
reduced viability at 1 (78.4±2.89%), 4 (54.67±3.46%,
P<0.05) and 24 (15.78±2.32%, P<0.05) h (Fig. 3).
N-chlorotaurine induces alterations in amino acids
and gliotoxin from A. fumigatus
To assess the effect of NCT on membrane permeability, the
amount of extracellular amino acids and gliotoxin levels fol-
lowing treatment with varying concentrations of NCT
(0.68–13.77mM) were determined via the ninhydrin colori-
metric assay and RP-HPLC, respectively. NCT (13.7mM)
significantly increased amino acid leakage (8.82±1.72 µg
mg 1 mycelium, P<0.0001) as compared to the control
(0.24±0.01 µg mg 1 mycelium), (Fig. 4).
A. fumigatus (ATCC 26933) mycelium treated with 6.8mM
NCT [25.67±0.43 ng (mg mycelium) 1, P<0.0001] and
0.68mM [38.38±1.55 ng (mg mycelium) 1 P<0.001] NCT
for 24 h displayed significantly less extracellular gliotoxin as
compared to control cells [64.15±3.34 ng (mg mycelium) 1]
Fig. 1. Susceptibility of A. fumigatus ATCC 26933 conidia (initial con-
centration 104 well 1) to N-chlorotaurine at concentrations ranging
from 0.21 to 55mM after 48 h growth in Sabouraud medium as deter-
mined by photometric analysis. N-chlorotaurine significantly reduced
the growth of A. fumigatus at concentrations between 55 and 6.8mM
as compared to the control, (*, P<0.05; ****, P<0.0001).
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. However, exposure to 13.77mM NCT resulted in a statisti-
cally significant increase in extracellular gliotoxin [88.19
±1.98 ng (mg mycelium) 1, P<0.001] (Fig. 5). Furthermore,
NCT (0.68 and 6.8mM) also reduced extracellular gliotoxin
levels in A. fumigatus (ATCC 46645) supernatants to 9.70
±8.19 ng (mg mycelium) 1, (P<0.01) and 18.56±11.78 ng
(mg mycelium) 1, (P<0.05) respectively, as compared to the
control mycelium [77.78±12.35 ng (mg mycelium) 1], (Fig.
S3a). This effect was observed with A. fumigatus (Af293)
with the same concentrations of NCT reducing extracellular
gliotoxin levels to 2.64±1.49 ng (mg mycelium) 1 and 13.81
±4.13 ng (mg mycelium) 1, respectively, as compared to the
control [65.87±13.79 ng (mg mycelium) 1, P<0.05], (Fig.
S3b). For intracellular gliotoxin quantification a similar
effect was observed. Treatment of A. fumigatus mycelium
with 13.77mM NCT resulted in a significant increase in
intracellular gliotoxin [9.42±1.50 ng (mg mycelium) 1,
P<0.01] relative to control mycelium [2.39±1.18 ng (mg
mycelium) 1]. Interesting, no gliotoxin was detected within
mycelium treated with 6.8mM, (Fig. 5).
The whole cell proteomic response of A. fumigatus
to N-chlorotaurine
Shotgun quantitative proteomic analysis was performed on
A. fumigatus (ATCC 26933) treated with 6.8mM NCT for
24 h as described. In total, 30 538 peptides were identified
representing 1932 proteins with two or more peptides and
210 (A. fumigatus NCT-treated versus control A. fumigatus)
proteins were determined to be differentially abundant
(ANOVA, P<0.05) with a fold change of >1.5. A total of 44
proteins were deemed exclusive (i.e. with LFQ intensities
present in all three replicates of one treatment and absent in
all threereplicates of the other treatment). These proteins
were also used in statistical analysis of the total differentially
expressed group following imputation of the zero values as
described. After data imputation, these proteins were
Fig. 2. The effect of N-chlorotaurine on growth of A. fumigatus ATCC
26933. A 24 h culture of A. fumigatus (105 ml 1) in Sabouraud dextrose
broth was supplemented with N-chlorotaurine (0.68, 6.8 and
13.77mM) or PBS (control). After 24 h, mycelia were weighed. N-chlor-
otaurine dose dependently decreased hyphal mass significantly after
24 h exposure, (**; P<0.01, ***; P<0.001, ****; P<0.0001).
Fig. 3. The viability of A. fumigatus ATCC 26933 conidia (initial concen-
tration; 5107 ml 1) after incubation in varying concentrations of N-
chlorotaurine [6.8, 13, 68mM (PBS)]) and PBS (control) for 0, 1, 4, 24 h.
Cells were removed, diluted, plated at each time point and % viability
calculated relative to the PBS 0 h control. N-chlorotaurine statically
significantly and dose dependently reduced the viability of A. fumigatus
conidia at a variety of concentrations over time as compared to the
control, (*; P<0.05).
Fig. 4. Amino acid quantification in A. fumigatus ATCC 26933 superna-
tants exposed to N-chlorotaurine (0.68, 6.8 and 13.77mM) or PBS
(control) for 24 h was determined by ninhydrin colorimetric assay. N-
chlorotaurine (13.77mM) significantly increased extracellular amino
acids as compared to the control, (****; P<0.0001).
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included in subsequent statistical analysis, (Fig. 6). A princi-
pal component analysis (PCA) performed on all filtered
proteins distinguished the NCT-treated A. fumigatus and
control A. fumigatus samples indicating a clear difference
between each proteome (Fig. S4).
Functional (GO term and FunCat) analysis revealed
enrichment for biological processes such as oxidation-
reduction process, proteolysis and translation, while
molecular functions such as nucleotide binding and oxi-
doreductase activity were significantly enriched within
the SSDA dataset (Fig. S5a). FunCat categories associ-
ated with electron transport, nitrogen, sulfur and sele-
nium metabolism, catabolism of nitrogenous compounds
and sulfate assimilation confirm A. fumigatus mycelium
responds to NCT by activation of a variety of processes
(Fig. S5b).
Proteins that were increased in abundance in NCT-treated
mycelium were enriched for ribosomal proteins [Ribosomal
protein S28e (23.1-fold), ribosomal biogenesis protein gar2
(5.5-fold), ribosome assembly factor mrt4 (5.1-fold), 40S
ribosomal protein S26 (2.2-fold), 60S ribosomal protein
L35Ae (1.7-fold), 60S ribosomal protein L12 (1.6-fold), ribo-
somal protein L16a (1.6-fold), 60S ribosomal protein L5
(1.5-fold), 60S ribosomal protein L27 (1.5-fold)] and tran-
scription and translation associated proteins [small
nucleolar ribonucleoprotein complex subunit (4.6-fold),
rRNA processing protein pwp1 (threefold), mRNA splicing
factor (prp17) (2.9-fold), RNA cytidine acetyltransferase
(2.3-fold), ATP-dependent RNA helicase has1 (2.2-fold),
eEF-3 (1.9-fold), eEF-1B (1.8-fold), pre-mRNA-splicing fac-
tor (1.7-fold), rRNA biogenesis protein RRP5 (1.6-fold)].
There was also increased abundance of proteins associated
with cell response to stress/drug [oxidoreductase, zinc-bind-
ing dehydrogenase family protein (11-fold), superoxide dis-
mutase (Cu-Zn); (7.7-fold), hsp30-like (5.6-fold), hsp30/
hsp42 (2.4-fold), nitroreductase family protein (2.2-fold),
glutathione S-transferase GstA (1.7-fold), ecm33 protein
(1.6-fold), MFS multidrug transporter (1.5-fold)], mito-
chondrion-associated proteins [cytochrome c oxidase sub-
unit VIa (12.4-fold), cytochrome c oxidase subunit 2 (1.7-
fold), cytochrome P450 phenylacetate 2-hydroxylase, puta-
tive (1.5-fold)] and secondary metabolite biosynthesis pro-
teins (nonribosomal peptide synthetase 8, nonribosomal
peptide synthetase 1, NRPS-like enzyme, fumipyrrole bio-
synthesis protein C), Table S1. Proteins that were decreased
in abundance in response to NCT were associated with ste-
rol biosynthesis [14-alpha sterol demethylase Cyp51A (1.5-
fold)] and secondary metabolism [NRPS-like enzyme, puta-
tive (7.3-fold), fumagillin dodecapentaenoate synthase (6.5-
fold), fumagillin biosynthesis methyltransferase (5.2-fold),
fumagillin biosynthesis acyltransferase (fivefold), pseurotin
Fig. 5. Gliotoxin quantification (extracellular; closed bars and left Y-axis, intracellular; open bars and right Y-axis) in A. fumigatus ATCC
26933 exposed to N-chlorotaurine (0.68, 6.8 and 13.77mM) or PBS (control) for 24 h was determined by RP-HPLC. N-chlorotaurine
decreased gliotoxin levels at a concentration of 0.68 and 6.8mM. However, N-chlorotaurine (13.77mM) significantly increased both
extracellular and intracellular gliotoxin levels as compared to the respective controls, (**; P<0.01, ***; P<0.001, ****; P<0.0001).
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biosynthesis protein C (4.3-fold), NRP synthetase 14 (3.9-
fold), fumagillin biosynthesis cluster P450 monooxygenase
(3.6-fold), pseurotin biosynthesis protein F (3.0-fold)],
Table S2.
DISCUSSION
In recent years it has become evident that environmental
use of triazoles has selected for multiazole and panazole-
resistant A. fumigatus isolates [42]. Mutations in the
Cyp51A gene or its transcriptional enhancer in its promoter
region is a common mechanism (50 to 80%) related to
altered or enhanced production of erg11 [43, 44]. In vitro
data, animal models and some clinical data demonstrate
that there may be a benefit of combination anti-fungal ther-
apy in treating Aspergillus infections [45]. NCT shows broad
spectrum antimicrobial activity, excellent tolerability in vivo
and may be a potential anti-fungal therapy for superficial
infections [21, 46, 47].
NCT significantly decreased the growth of A. fumigatus
(ATCC 26933, ATCC46645, Af293) conidia in an in vitro
susceptibility assay at concentrations ranging from 6.8 to
55mM in sabouraud medium (Figs 1, S1-d,) and MEM
supplemented with 5% v/v FCS (Fig. S1) as compared to the
relevant controls. The lower effect in MEM can be explained
by reaction of NCT with reducing components of the FCS,
which is connected with a loss of oxidative activity (chlorine
consumption, [46, 48]). NCT reduced the biomass forma-
tion of A. fumigatus (ATCC 26933, ATCC46645, Af293)
hyphae after 24 h at concentrations between 0.68 and
13.77mM. Incubation of A. fumigatus conidia in NCT
decreased their viability at 1, 4 and 24 h. The results are in
agreement with the fungicidal activity of NCT against yeasts
and moulds found in previous studies [29–31, 47, 49].
Within 1min, NCT forms covalent chlorine covers (chlori-
nation of the external protein matrix of the microbe)
around Staphylococcus aureus, Escherichia coli, P. aerugi-
nosa and C. albicans [50, 51], which is associated with a loss
of virulence [29, 31, 32]. Longer incubation leads to cellular
leakage and inactivation of pathogens [50]. In this work,
incubation of 24 h preformed mycelium in NCT
(13.77mM) significantly increased extracellular amino acid
levels indicating small molecule leakage from mycelium,
which would damage the cells’ ability to respire, grow and
activate an oxidative stress response. Amino acid leakage is
also observed with a variety of antimicrobials [52–55].
Fig. 6. Shotgun proteomics of 24 h preformed A. fumigatus ATCC 26933 mycelium exposed to N-chlorotaurine (6.8mM) for 24 h. Vol-
cano plots showing the distribution of quantified proteins according to P-value ( log10 P-value) and fold change (log2 mean LFQ inten-
sity difference). Proteins above the horizontal line are considered statistically significant (P-value<0.05) and those to the right and left
of the vertical lines indicate relative fold changes±1.5. N-chlorotaurine increased the abundance of proteins associated with cellular
response to drug, ribosomal biogenesis and secondary metabolism.
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Interestingly, incubation of mycelium in 0.68 and 6.8mM
NCT decreased extracellular gliotoxin levels amongst A.
fumigatus strains (Figs 5, S3a and S3b). This was observed
previously where NCT diminished the activity of gliotoxin
by reduction of the disulphide bridge, which is essential to
its activity [30]. However, our results indicate that these
NCT treatments also reduced intracellular gliotoxin levels
(Fig. 5). Furthermore, NCT leads to decreased production
of secreted aspartyl proteinases from Candida spp. [29].
Conversely, incubation of mycelium in the higher concen-
tration of 13.77mM NCT resulted in a significant increase
in intracellular and extracellular gliotoxin concentration. At
this concentration, reduced growth and increased gliotoxin
production and secretion from A. fumigatus was observed.
Therefore, we hypothesize that gliotoxin was liberated by
active and/or passive mechanisms, through the damaged
cell and that this effect overlays the reduced production of
the toxin at low concentrations. Treatment of A. fumigatus
with caspofungin and amphotericin resulted in a significant
increase in intracellular and extracellular gliotoxin as a
result of halted growth, which was observed in mycelium
treated with 13.77mM NCT [54, 56].
Shotgun proteomics was employed to determine the effect
of NCT (6.8mM) on A. fumigatus (ATCC 26933) after 24 h
exposure. A. fumigatus responds to NCT by increasing the
abundance of ribosomal proteins and proteins associated
with transcription and translation. Shenton et al. 2006
found that a hydrogen peroxide treatment increased the
number of ribosomal proteins, which may be utilized once
the response to oxidative stress has subsided for transcrip-
tional and translational remodelling [57].
There was also an increased abundance of proteins associ-
ated with cellular response to stress [e.g. oxidoreductase,
superoxide dismutase (Cu-Zn), hsp30-like, hsp30/hsp42,
nitroreductase family protein, glutathione s-transferase
GstA, MFS multidrug transporter]. A. fumigatus responds
to NCT by an increase in superoxide dismutase, which
detoxifies superoxide anions, glutathione s-transferase,
which quenches reactive hydroxyl free radicals, a range of
heat shock proteins and nitroreductase family protein. This
may be an attempt by the fungus to neutralize active chlo-
rine compounds it would encounter within the phagosome.
There was an increase in the abundance of some secondary
metabolism proteins which play a role in response to oxida-
tive stress [e.g. nonribosomal peptide synthetase 1 (Pes1),
non-ribosomal peptide synthetase 8 (Pes3)]. Pes1 confers
protection against oxidative stress as the delta pes1 mutant
showed attenuated virulence in G. mellonella, increased sen-
sitivity to neutrophil mediated phagocytosis, which was
mediated by changed conidial surface morphology and
increased hydrophilicity [9]. Paradoxically, pes3 disruption
augments A. fumigatus virulence (in G. mellonella) and
increases fungal burden (murine pulmonary aspergillosis
model), possibly due to defective innate immune recogni-
tion of A. fumigatus in vivo [10]. Pes3 deletion, on the other
hand, increases susceptibility to voriconazole, produces
shorter germlings and decreased surface beta glucan.
Following NCT treatment, there was a significant decrease
in the abundance of a range of proteins involved in fumagil-
lin and pseurotin biosynthesis (NRPS-like enzyme, fumagil-
lin dodecapentaenoate synthase, pseurotin biosynthesis
protein B, fumagillin biosynthesis methyltransferase, fuma-
gillin biosynthesis acyltransferase, pseurotin biosynthesis
protein C, NRP synthetase 14, fumagillin biosynthesis clus-
ter P450 monooxygenase, pseurotin biosynthesis protein F).
Fumagillin is a toxin produced during hyphal development
in A. fumigatus. The toxin has well characterized amoebici-
dal activity, can retard the ciliary beat frequency of pulmo-
nary epithelial cells, and can inhibit angiogenesis and
microbicidal activity of human neutrophils and insect hae-
mocytes [6, 58–60].
The results presented here indicate that NCT reduces the
expression of a number of virulence factors of A. fumigatus
similar to Candida spp. [29], before the killing of the fungus
occurs. This may be caused by several pathways. Direct
chlorination and oxidation reactions leading to abrogation
of synthesis pathways are possible as well as consumption of
most of the energy of the fungus by activation of anti-oxida-
tive pathways. There was also a significant decrease in the
azole target protein 14-alpha sterol demethylase (erg11,
gene product of cyp51A), which is implicated amongst 50–
80% of A. fumigatus resistance isolates.
These results demonstrate that NCT is active against A.
fumigatus and reduces growth, biomass formation and
conidial viability. NCT reduces the gliotoxin levels from A.
fumigatus at low, sublethal concentrations and causes
increased intracellular and extracellular gliotoxin levels at
higher ones. NCT triggers oxidative stress response in A.
fumigatus and reduces the abundance of proteins associated
with fumagillin and ergosterol biosynthesis. Understanding
the mode of action of NCT is a good basis for both further
elucidating its role in the human defense system and its
potential clinical application for treatment of aspergillosis.
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